SS
FLAC

Steve Schonfeld’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Steve Schonfeld’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-194,685
Closed -$1.94M – 3347
2022
Q3 		$1.94M Buy
194,685
+163,131
+517% +$1.62M 0.02% 875
2022
Q2 		$311K Buy
31,554
+2,526
+9% +$24.9K ﹤0.01% 1646
2022
Q1 		$286K Sell
29,028
-3
-0% -$29 ﹤0.01% 1722
2021
Q4 		$283K Hold
29,031
– – ﹤0.01% 1540
2021
Q3 		$284K Buy
29,031
+9,650
+50% +$94.2K ﹤0.01% 1567
2021
Q2 		$189K Buy
19,381
+8,956
+86% +$88.4K ﹤0.01% 1692
2021
Q1 		$104K Buy
+10,425
New +$106K ﹤0.01% 1630

Steve Schonfeld's FLAC Position: Q4 2022 in Review

Steve Schonfeld sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 194,685 shares — an estimated $1.94M sold.

Steve Schonfeld first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.94M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

  • Steve Schonfeld reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Steve Schonfeld sold 194,685 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.94M.
  • Steve Schonfeld first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
  • Steve Schonfeld's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.94M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.